Meanwhile, long-term use also disrupts intestinal microbiota (bacteria and fungi), risks multidrug-resistant fungi, and carries hepatotoxic or even fatal side effects 169,170
Medications like Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for weight management
Clinical trials have shown that patients using Mounjaro can lose up to 22.5% of their body weight, compared to about 15% with Ozempic at maximum doses
In addition to GLP-1 use, older patients and those with a history of cerebrovascular accident also had a significantly higher risk of developing nAMD
Results come back faster, allowing quicker release of batches
Ongoing research highlights the significant clinical potential of incretin-based therapies, especially in emerging areas such as central nervous system disorders, substance use, and post-transplant care